BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33816578)

  • 1. Different Expressions of Pericardial Fluid MicroRNAs in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy and Ischemic Heart Disease Undergoing Ventricular Tachycardia Ablation.
    Khudiakov AA; Panshin DD; Fomicheva YV; Knyazeva AA; Simonova KA; Lebedev DS; Mikhaylov EN; Kostareva AA
    Front Cardiovasc Med; 2021; 8():647812. PubMed ID: 33816578
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating microRNAs in arrhythmogenic right ventricular cardiomyopathy with ventricular arrhythmia.
    Yamada S; Hsiao YW; Chang SL; Lin YJ; Lo LW; Chung FP; Chiang SJ; Hu YF; Tuan TC; Chao TF; Liao JN; Lin CY; Chang YT; Te ALD; Tsai YN; Chen SA
    Europace; 2018 Jun; 20(FI1):f37-f45. PubMed ID: 29036525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiofrequency Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC).
    Romero J; Grushko M; Briceño DF; Natale A; Di Biase L
    Curr Cardiol Rep; 2017 Sep; 19(9):82. PubMed ID: 28779285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling of differentially expressed microRNAs in arrhythmogenic right ventricular cardiomyopathy.
    Zhang H; Liu S; Dong T; Yang J; Xie Y; Wu Y; Kang K; Hu S; Gou D; Wei Y
    Sci Rep; 2016 Jun; 6():28101. PubMed ID: 27307080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating miR-185-5p as a Potential Biomarker for Arrhythmogenic Right Ventricular Cardiomyopathy.
    Sacchetto C; Mohseni Z; Colpaert RMW; Vitiello L; De Bortoli M; Vonhögen IGC; Xiao K; Poloni G; Lorenzon A; Romualdi C; Bariani R; Mazzotti E; Daliento L; Bauce B; Corrado D; Thum T; Rampazzo A; de Windt LJ; Calore M
    Cells; 2021 Sep; 10(10):. PubMed ID: 34685557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Right ventricular scar-related ventricular tachycardia in nonischemic cardiomyopathy: Electrophysiological characteristics, mapping, and ablation of underlying heart disease.
    Kumar S; Baldinger SH; Kapur S; Romero J; Mehta NK; Mahida S; Fujii A; Tedrow UB; Stevenson WG
    J Cardiovasc Electrophysiol; 2018 Jan; 29(1):79-89. PubMed ID: 28940781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, Predictors, and Success of Ventricular Tachycardia Catheter Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy (from the Nordic ARVC Registry).
    Christiansen MK; Haugaa KH; Svensson A; Gilljam T; Madsen T; Hansen J; Holst AG; Bundgaard H; Edvardsen T; Svendsen JH; Platonov PG; Jensen HK
    Am J Cardiol; 2020 Mar; 125(5):803-811. PubMed ID: 31924321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of ICD electrograms analysis to distinguish endocardial vs epicardial ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy.
    Kodali S; Shirai Y; Callans DJ; Zado ES; Marchlinski FE; Santangeli P
    J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1526-1534. PubMed ID: 31187564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac sympathectomy for refractory ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy.
    Assis FR; Krishnan A; Zhou X; James CA; Murray B; Tichnell C; Berger R; Calkins H; Tandri H; Mandal K
    Heart Rhythm; 2019 Jul; 16(7):1003-1010. PubMed ID: 30677492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arrhythmogenic right ventricular cardiomyopathy, clinical manifestations, and diagnosis.
    Haugaa KH; Haland TF; Leren IS; Saberniak J; Edvardsen T
    Europace; 2016 Jul; 18(7):965-72. PubMed ID: 26498164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrocardiographic (ECG) clues to differentiate idiopathic right ventricular outflow tract tachycardia (RVOTT) from arrhythmogenic right ventricular cardiomyopathy (ARVC).
    Emkanjoo Z; Mollazdeh R; Alizadeh A; Kheirkhah J; Mohammadi Z; Khalili M; Azhari A; Shahrzad S
    Indian Heart J; 2014; 66(6):607-11. PubMed ID: 25634393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catheter ablation reduces ventricular tachycardia burden in patients with arrhythmogenic right ventricular cardiomyopathy: insights from a north-western French multicentre registry.
    Souissi Z; Boulé S; Hermida JS; Doucy A; Mabo P; Pavin D; Anselme F; Auquier N; Ninni S; Coisne A; Brigadeau F; Deken-Delannoy V; Klug D; Lacroix D
    Europace; 2018 Feb; 20(2):362-369. PubMed ID: 28017936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA profiling of pericardial fluid samples from patients with heart failure.
    Kuosmanen SM; Hartikainen J; Hippeläinen M; Kokki H; Levonen AL; Tavi P
    PLoS One; 2015; 10(3):e0119646. PubMed ID: 25763857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Different Substrate Characteristics of Arrhythmogenic Triggers in Idiopathic Right Ventricular Outflow Tract Tachycardia and Arrhythmogenic Right Ventricular Dysplasia: New Insight from Noncontact Mapping.
    Do VB; Tsai WC; Lin YJ; Higa S; Yagi N; Chang SL; Lo LW; Chung FP; Liao JN; Huang YC; Chan CS; Huang HK; Hu YF; Tsao HM; Chen SA
    PLoS One; 2015; 10(10):e0140167. PubMed ID: 26488594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic expression is a prerequisite for malignant arrhythmic events and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy.
    Zorzi A; Rigato I; Pilichou K; Perazzolo Marra M; Migliore F; Mazzotti E; Gregori D; Thiene G; Daliento L; Iliceto S; Rampazzo A; Basso C; Bauce B; Corrado D
    Europace; 2016 Jul; 18(7):1086-94. PubMed ID: 26138720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of Catheter Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy Without Background Implantable Cardioverter Defibrillator Therapy: A Multicenter International Ventricular Tachycardia Registry.
    Santangeli P; Tung R; Xue Y; Chung FP; Lin YJ; Di Biase L; Zhan X; Lin CY; Wei W; Mohanty S; Burkhardt DJ; Zado ES; Callans DJ; Marchlinski FE; Wu S; Chen SA; Natale A
    JACC Clin Electrophysiol; 2019 Jan; 5(1):55-65. PubMed ID: 30678787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting arrhythmic risk in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta-analysis.
    Bosman LP; Sammani A; James CA; Cadrin-Tourigny J; Calkins H; van Tintelen JP; Hauer RNW; Asselbergs FW; Te Riele ASJM
    Heart Rhythm; 2018 Jul; 15(7):1097-1107. PubMed ID: 29408436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of ripple mapping for identification of slow conduction channels during ventricular tachycardia ablation in the setting of arrhythmogenic right ventricular cardiomyopathy.
    Xie S; Kubala M; Liang JJ; Yang J; Desjardins B; Santangeli P; van der Geest RJ; Schaller R; Riley M; Supple G; Frankel DS; Callans D; Pac EZ; Marchlinski F; Nazarian S
    J Cardiovasc Electrophysiol; 2019 Mar; 30(3):366-373. PubMed ID: 30575168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catheter ablation of electrical storm in patients with arrhythmogenic right ventricular cardiomyopathy.
    Laredo M; Oliveira Da Silva L; Extramiana F; Lellouche N; Varlet É; Amet D; Algalarrondo V; Waintraub X; Duthoit G; Badenco N; Maupain C; Hidden-Lucet F; Maury P; Gandjbakhch E;
    Heart Rhythm; 2020 Jan; 17(1):41-48. PubMed ID: 31284048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sinus rhythm detection of conducting channels and ventricular tachycardia isthmus in arrhythmogenic right ventricular cardiomyopathy.
    Fernández-Armenta J; Andreu D; Penela D; Trucco E; Cipolletta L; Arbelo E; Berne P; María Tolosana J; Pedrote A; Brugada J; Mont L; Berruezo A
    Heart Rhythm; 2014 May; 11(5):747-54. PubMed ID: 24561159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.